000 01542 a2200457 4500
005 20250513054045.0
264 0 _c19950117
008 199501s 0 0 eng d
022 _a0022-3565
040 _aNLM
_beng
_cNLM
100 1 _aBjörk, A
245 0 0 _aIn the search for a novel class of antipsychotic drugs: preclinical pharmacology of FG5803, a 1-piperazinecarboxamide derivative.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cDec 1994
300 _a1338-47 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntipsychotic Agents
_xpharmacology
650 0 4 _aApomorphine
_xpharmacology
650 0 4 _aAutoreceptors
_xdrug effects
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aFemale
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aProlactin
_xblood
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Dopamine
_xdrug effects
650 0 4 _aReceptors, Serotonin
_xdrug effects
650 0 4 _aSerotonin Antagonists
_xpharmacology
700 1 _aChristensson, E
700 1 _aAlbinsson, A
700 1 _aGustafsson, B
700 1 _aPettersson, E
700 1 _aPettersson, G
700 1 _aSvartengren, J
700 1 _aAndersson, G
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 271
_gno. 3
_gp. 1338-47
999 _c7995773
_d7995773